MN-ECOLAB-INC
18.9.2023 14:36:33 CEST | Business Wire | Press release
Ecolab, a global sustainability leader offering water solutions and services, today announced findings from the inaugural Ecolab Watermark™ Study. The global consumer research examined the state of water stewardship through water’s importance, usage, connection to climate and responsibility among key consumer populations around the world.
By 2030, the planet is set to face a 56% water deficit, according to the World Resources Institute, and 1.6 billion people will lack safely managed drinking water, according to the United Nations. It’s amid this pressing water crisis that Ecolab developed the Ecolab Watermark Study to identify trends, help educate and generate action across industry stakeholders, specifically those in Asia/Pacific, China, Europe, India/Middle East/Africa (IMEA), Latin America and the United States (U.S.).
Among its global findings, the Ecolab Watermark Study uncovered several critical water-related trends:
- Access to clean and safe water is a paramount concern for consumers in every region. Latin America (92%), China (85%) and the U.S. (81%) have the highest percentage of consumers who are more concerned about access to clean and safe water than other climate-related issues, such as pollution or climate change.
- Consumers hold governments and businesses most responsible for water conservation. However, consumers do not believe these leaders care enough about their impact on water or climate change. This was most pronounced in the U.S., Europe, Latin America and Asia/Pacific, where between 42% and 46% of people believed their leaders cared.
- Consumers believe that industry has no clear plan to address water scarcity, despite the perceived responsibility and importance. This concern is most evident in China (82%), Latin America (78%), and IMEA (78%), but also noticeably visible in Europe (66%), the U.S. (65%) and Asia/Pacific (60%).
“The water crisis impacts communities regardless of location and is often overlooked in the global response to climate change. As we continue our work to transform the way the world thinks about water, the results from the Ecolab Watermark Study should galvanize leaders to assume a larger role in protecting this precious and finite resource,” said Christophe Beck, chairman and chief executive officer, Ecolab. “Time is running out to address this challenge, and consumers across the world are saying that businesses must act now. The good news for industry is that meeting this responsibility can deliver positive sustainability and business outcomes.”
In response to the perceived lack of accountability, consumers are themselves adopting environmentally friendly buying behaviors. According to the study, consumers are willing to stop purchasing products that require a significant amount of water to produce, as well as pay more for goods that are made using sustainable business practices, particularly in IMEA (88%), China (85%) and Latin America (81%).
Despite the known challenges, consumers remain optimistic that the water crisis can be mitigated with proper and immediate action. On average, three out of four consumers across the globe believe that water scarcity can be effectively addressed, according to the study, with the optimism most evident in Latin America (84%), IMEA (83%) and China (78%).
“If industry is not at the table to advocate and develop climate and water solutions that protect our communities, we will continue to fuel consumer sentiment that we’re not doing enough,” said Emilio Tenuta, senior vice president and chief sustainability officer, Ecolab. “By focusing solely on water and consumer perceptions of the ongoing crisis, the Ecolab Watermark Study provides unique insights on where and how stakeholders—whether its government, businesses, NGOs or even individuals—can work together to successfully address critical global challenges.”
In addition to offering global and regional findings, the Ecolab Watermark Study includes data for 15 individual countries. The U.S.-specific data showed that 81% of consumers are concerned about access to clean and safe water, and they consider businesses and governments to have the highest level of responsibility when it comes to funding for water conservation. Plus, 65% of U.S. consumers agree that businesses and manufacturers lack clear guidance and plans to combat water scarcity. Lastly, even though less than half of U.S. consumers believe that business and government leaders care about climate change or water conservation, 70% remain optimistic that water scarcity can be effectively addressed.
The Ecolab Watermark Study was conducted in partnership with Morning Consult in 2023 among a sample of general population adults. Ecolab will update and release new editions of its Ecolab Watermark Study annually. For detailed results, including an interactive dashboard, visit watermark.ecolab.com.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on a century of innovation, Ecolab has annual sales of $14 billion, employs more than 47,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, life sciences, hospitality and industrial markets. www.ecolab.com
Follow us on LinkedIn @Ecolab, Twitter @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.
About the Ecolab Watermark™ Study
Launched in 2023, the Ecolab Watermark Study is annual research conducted by Ecolab. The global study reports on the state of water stewardship by measuring water’s importance, usage, connection to climate and responsibility among key consumer populations. This research was conducted between February 15 – March 3, 2023, among a sample of general population adults. The interviews were conducted online. Results from the full study have a margin of error of plus or minus 2–3 percentage points. Some geographies may be weighted with fewer variables depending on local census data availability.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230918273418/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
